.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Surrogate endpoints often expedite the regulatory approval of cancer therapies by providing early signals of efficacy. In resected melanoma, researchers recently examined the validity of recurrence-based metrics. Specifically, they evaluated melanoma surrogate endpoints like disease-free survival (DFS) and distant metastasis-free survival (DMFS) to predict long-term clinical outcomes.
A comprehensive study analyzed data from 10,379 patients with AJCC stage I-III melanoma treated at five international centers. The researchers aimed to determine if DFS or DMFS could reliably replace disease-specific survival (DSS). Interestingly, the results showed that both DFS and DMFS had strong correlations with DSS at specific time horizons. Furthermore, trial-level surrogacy for DFS was strongest between 24 and 36 months, with an R² value reaching 0.95. Similarly, DMFS demonstrated high surrogacy for DSS from 24 to 48 months. These findings suggest that recurrence-based endpoints are excellent indicators of cancer-specific mortality in adjuvant settings.
While the link between recurrence and disease-specific death is clear, the connection to overall survival (OS) remains problematic. The study found that correlations with OS were weak across all horizons. Moreover, this discrepancy often arises because non-cancer deaths or subsequent treatments can dilute the trial-level effects of the primary drug on OS. Consequently, many experts suggest that OS might not be the most suitable primary endpoint for adjuvant melanoma trials. Instead, focusing on DSS or validated surrogates could significantly streamline the evaluation of novel therapies. Additionally, individual-level surrogacy was also evaluated to ensure patient-level consistency.
A surrogate endpoint is a measure, such as disease-free survival, used as a substitute for a clinically meaningful endpoint like overall survival. These endpoints allow researchers to assess treatment benefits faster than waiting for long-term survival data.
Overall survival counts all deaths, including those unrelated to cancer. Because melanoma patients may live for many years and receive various subsequent treatments after a recurrence, isolating the effect of a single adjuvant therapy on total mortality is challenging.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional physician-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study of 10,379 melanoma patients evaluates DFS and DMFS as surrogate endpoints for survival. Results show strong trial-level surrogacy for melanoma-specific survival but weak correlation with overall survival, questioning the use of OS as a primary endpoint in adjuvant trials.
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
